Skip to main content

Table 1 Baseline clinical, angiographic and medication according to Lp(a) categories

From: Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study

 

All patients (n=4,469)

Lp(a) categories(mg/dl)

p value

 

<10 (n=1,402)

10-30 (n=1,458)

≥30 (n=1,609)

n=8,550

n=950

n=3,714

n=3,886

Age, yrs

59.51±10.27

59.15±10.22

59.30±10.42

60.03±10.16

0.041

Sex, male(%)

3577(80.0)

1163(83.0)

1166(80.0)

1248(77.6)

0.001

BMI, kg/m2

25.98±3.11

26.15±3.10

26.00±3.12

25.83±3.08

0.018

Risk factors

     

  Hypertension

3034(67.9)

954(68.0)

975(66.9)

1105(68.7)

0.559

Hypercholesterolemia

3202(71.6)

1024(73.0)

1042(71.5)

1136(70.6)

0.329

  Diabetes mellitus

1507(33.7)

499(35.6)

468(32.1)

540(33.6)

0.140

  Current smoker

2722(60.9)

886(63.2)

906(62.1)

930(57.8)

0.005

Family history of CAD

1114(24.9)

335(23.9)

349(23.9)

430(26.7)

0.189

  COPD

117(2.6)

29(2.1)

38(2.6)

50(3.1)

0.205

Laboratory findings

     

  HbA1c,%

6.30(5.90-7.20)

6.30(5.90-7.20)

6.30(5.90-7.10)

6.30(5.90-7.20)

0.277

  Glucose, mmol/L

6.32±2.26

6.39±2.23

6.30±2.37

6.28±2.18

0.324

  LVEF, %

61.15±8.15

61.77±7.88

60.80±8.29

60.93±8.23

0.003

  Hs-CRP, mg/L

1.52(0.76-3.55)

1.36(0.73-2.83)

1.58(0.74-3.92)

1.69(0.82-4.04)

< 0.001

  eGFR, ml/min

89.64±16.02

90.22±15.51

89.49±16.61

89.28±15.89

0.248

  HDL-C, mmoL/L

1.02±0.28

1.01±0.28

1.01±0.27

1.05±0.28

< 0.001

  LDL-C, mmoL/L

2.41±0.89

2.25±0.84

2.37±0.88

2.57±0.91

< 0.001

  TG, mmoL/L

1.75±1.03

1.94±1.29

1.70±0.96

1.61±0.78

< 0.001

  TC, mmoL/L

4.08±1.05

3.96±1.03

4.02±1.04

4.23±1.06

< 0.001

  Lp(a), mg/dl

18.93(7.90-43.03)

5.06(3.13-7.43)

17.36(13.08-23.14)

55.69(40.18-79.75)

< 0.001

Presentation

    

0.045

  ACS

2284(51.1)

702(50.1)

784(53.8)

798(49.6)

 

  Stable angina

2185(48.9)

700(49.9)

674(46.2)

811(50.4)

 

Left main involvement

126(2.8)

36(2.6)

37(2.5)

53(3.3)

0.355

Mean SYNTAX score

11.46±8.54

11.17±8.37

11.48±8.55

11.69±8.68

0.259

Medication at discharge

     

  aspirin

4407(98.6)

1384(98.7)

1436(98.5)

1587(98.6)

0.873

  clopidogrel

4397(98.4)

1379(98.4)

1439(98.7)

1579(98.1)

0.465

  ACEI/ARB

2561(57.3)

803(57.3)

828(56.8)

930(57.8)

0.852

  Statin

4256(95.2)

1334(95.1)

1386(95.1)

1586(95.5)

0.859

  β-blocker

4071(91.1)

1260(89.9)

1327(91.0)

1484(92.2)

0.076

  CCB

2121(47.5)

668(47.6)

660(45.3)

793(49.3)

0.083

  1. Continuous values are summarized as mean±SD, median (Q1-Q3) and categorical variables as n (percentage)
  2. Lp(a) = lipoprotein(a), BMI = body mass index, CAD = coronary artery disease COPD = chronic obstructive pulmonary disease; HbA1c = glycated hemoglobin; LVEF = left ventricular ejection fraction; Hs-CRP = high-sensitivity C-reactive protein; eGFR = estimated glomerular filtration rate; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; TG = triglyceride; TC = total cholesterol; ACS = acute coronary syndrome; ACEI/ARB = angiotensin converting enzyme inhibitor/angiotensin receptor blockers; CCB = calcium channel blockers